LLME
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LLME, covering 2013-12-10 to 2013-12-10. Get the full timeline:
Most recent: Clinical Trial Update: Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation [Phase 1, Phase 2]